We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
109 hedge funds and large institutions have $397M invested in Amphastar Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 40 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
56% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 9
10% more capital invested
Capital invested by funds: $363M → $397M (+$34.8M)
5% more funds holding
Funds holding: 104 → 109 (+5)
1.02% more ownership
Funds ownership: 43.92% → 44.94% (+1%)
18% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 40
Holders
109
Holders Change
+5
Holders Change %
+4.81%
% of All Funds
2.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
33
Reduced
40
Closed
9
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$9K
Top Buyers
| 1 |
Millennium Management
New York
|
+$5.19M |
| 2 |
MWNA
Marshall Wace North America
New York
|
+$2.88M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.77M |
| 4 |
ACM
Argent Capital Management
St Louis,
Missouri
|
+$2.03M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$2.01M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$6.08M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.94M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$1.3M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.21M |
| 5 |
Citigroup
New York
|
-$998K |
